Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 1:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2329–2352 of 17,766 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: Hip Arthroscopy
Interventions: Hip Capsule Repair; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 50 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2040
U.S. locations: 3
States / cities: Scottsdale, Arizona • Westmont, Illinois • Rochester, Minnesota

Conditions: Intraocular Pressure
Interventions: Mirabegron, Placebo; Drug
Lead sponsor: Astellas Pharma Inc; Industry
Eligibility: 18 Years and older
Enrollment: 321 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: Tempe, Arizona • Lincoln, Nebraska

Conditions: Diabetes, Cardiovascular Disease, Substance Abuse Disorder, Mental Health Disorder
Interventions: Co-developed IT intervention; Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: Not listed
Enrollment: 6,767 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: PTSD
Interventions: Exposure Therapy; Behavioral
Lead sponsor: University of Central Florida; Other
Eligibility: 18 Years to 64 Years
Enrollment: 134 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Chronic Renal Disease
Interventions: Arginine and canola oil, Coromega and Arginine; Dietary Supplement
Lead sponsor: University of Cincinnati; Other
Eligibility: Not listed
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2005
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Durham, North Carolina

Conditions: Schizophrenia
Interventions: Not listed
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 55 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2021
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Spinal Cord Injuries
Interventions: Sprint Interval Training (SIT), Usual Care, Home Ergometer (ERGO), Motivational Interviewing (MI); Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Dermatitis, Atopic
Interventions: PF-04965842 100 mg, PF-04965842 200 mg, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 12 Years and older
Enrollment: 391 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 28
States / cities: Anaheim, California • Los Alamitos, California • Rolling Hills Estates, California + 20 more

Conditions: Child Development, Parents, Prosocial and Emotional Well-Being
Interventions: ColorBRAVE; Behavioral
Lead sponsor: Tulane University; Other
Eligibility: 5 Years to 100 Years
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Aging
Interventions: MedX 1116 Rehab Console, Sham MedX 1116 Rehab Console; Device
Lead sponsor: University of Florida; Other
Eligibility: 62 Years to 99 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2023
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: Urinary Tract Infections, Urinary Retention Postoperative, Pelvic Organ Prolapse
Interventions: Methenamine Hippurate 1 g tablet, Placebo tablet; Drug
Lead sponsor: TriHealth Inc.; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Myopia
Interventions: Atropine, MiSight contact lenses; Drug · Device
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 5 Years to 12 Years
Enrollment: 348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Warm Autoimmune Hemolytic Anemia (wAIHA)
Interventions: parsaclisinib, placebo; Drug
Lead sponsor: Incyte Corporation; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 10
States / cities: Los Angeles, California • Whittier, California • Miami, Florida + 6 more

Conditions: Participants Must be Women Aged 25 Years or Older, Participants Should Have no Self-reported History of Heart Disease or Stroke, Participants Should Have no Terminal Illness or Diagnosed Cognitive Impairment, Including Alzheimer's Disease, Participants Should Not be a Healthcare Professionals or Healthcare Trainees, Participants Should Not be Employed in the Healthcare Field, Participants Should Reside in the United States and be a University of California, San Francisco Health Patient, Participants Should Possess a Smartphone With an Active Data Plan or Access to Wi-Fi
Interventions: HeartBot II Program, Waitlist Control; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 25 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Photodamaged Skin
Interventions: Right Arm treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light Therapy, Left Arm treated with vehicle serum and Intense Pulsed Light Therapy; Drug
Lead sponsor: Goldman, Butterwick, Fitzpatrick and Groff; Other
Eligibility: 50 Years to 80 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Suspected Eosinophilic Esophagitis
Interventions: Esophageal dilation, Steroid and Proton Pump Inhibitor Therapy; Procedure · Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Health Behavior
Interventions: Kombucha beverage; Dietary Supplement
Lead sponsor: University of California, San Diego; Other
Eligibility: 21 Years to 55 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Bipolar Disorder, Bipolar Depression, Depression
Interventions: quetiapine fumarate (Seroquel), paroxetine, mood stabilizing activity; Drug · Behavioral
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 676 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 28
States / cities: Phoenix, Arizona • Little Rock, Arkansas • National City, California + 25 more

Conditions: HIV
Interventions: PATH For Triples, Treatment as Usual; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus, Type 2, Chronic Disease, Stroke, Heart Failure Chronic, Hypertension (HTN)
Interventions: Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM); Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Autism, Autism Disorder, ADHD - Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder
Interventions: Virtual Reality; Behavioral
Lead sponsor: New York Institute of Technology; Other
Eligibility: 9 Years to 18 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Old Westbury, New York

Conditions: Hypertension, Hypertension, Systolic, Hypertension, Essential
Interventions: Medtronic Astra/Azure DR MRI IPG with AVIM therapy Activated, Medtronic Astra/Azure DR MRI IPG with AVIM therapy Deactivated; Device
Lead sponsor: Orchestra BioMed, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 316 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 72
States / cities: Scottsdale, Arizona • Glendale, California • Newport Beach, California + 60 more

Conditions: Substance-Related Disorders, Alcohol-Related Disorders
Interventions: The Women's Recovery Group, Group Drug Counseling; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years and older
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Belmont, Massachusetts • Fall River, Massachusetts

Conditions: Respiratory Syncytial Virus Infection, Healthy Volunteers, Human Metapneumovirus
Interventions: RSV/hMPV vaccine candidate Dose L, RSV/hMPV vaccine candidate Dose A, RSV/hMPV vaccine candidate Dose B, Placebo; Biological
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Eligibility: 60 Years and older
Enrollment: 646 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 10
States / cities: Los Alamitos, California • Los Angeles, California • Rolling Hills Estates, California + 7 more

Search by objective public record fields.

CREST: Capsular Repair During Hip Arthroscopy

A Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects

Reverse Innovation and Patient Engagement to Improve Quality of Care and Patient Outcomes

Effectiveness of Trauma Management Therapy and Prolonged Exposure Therapy

Nutrient Levels Alter Transplant Outcome

Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies

Feasibility of a Sprint Interval Training Program During Inpatient Spinal Cord Injury Rehabilitation

Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis

Leveraging Families to Promote Healthy Socio-Emotional Development in Children

Revitalize Cognition: Near Infrared Stimulation in Older Adults

Urinary Track Infection Prevention After Urogynecological Surgery

Myopia Control: a Comparison Study Between Atropine and MiSight

Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia

RCT of HeartBot in Women

Study Comparing Two Serums With Intense Pulsed Light for the Treatment of Moderate to Severe Photodamage and Crepiness on the Forearms

Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis

Effect of Kombucha Consumption on the Microbiome in Healthy Subjects

Seroquel in Bipolar Depression Versus SSRI

PATH For Triples Study: Medication and Lifestyle Adherence for HIV+ Patients

Improving the Collaborative Health of Adult Dyads

How Virtual Reality Can Help Neurodivergent Children Improve Their Attention

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

Women's Recovery Group (WRG) Study - A Randomized Controlled Stage II Trial

Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate